Surgical Management of Local Recurrences of Renal Cell Carcinoma

Ömer Acar, Öner Şanli

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Surgical resection either in the form of radical nephrectomy or in the form of partial nephrectomy represents the mainstay options in the treatment of kidney cancer. In most instances, resecting the tumor bearing kidney or the tumor itself provides durable cancer specific survival rates. However, recurrences may rarely develop in the renal fossa or remnant kidney. Despite its rarity, locally recurrent RCC is a challenging condition in terms of the possible management options and relatively poor prognosis. If technically feasible, wide surgical excision and ensuring negative surgical margins are the most effective treatment options. Repeat surgeries (completion nephrectomy, excision of locally recurrent tumor, or repeat partial nephrectomy) may often be complicated, and perioperative morbidity is a major concern. Open approach has been extensively applied in this context and 5-year cancer specific survival rates have been reported to be around 50%. The roles of minimally invasive surgical options (laparoscopic and robotic approach) and nonsurgical alternatives (cryoablation, radiofrequency ablation) have yet to be described. In selected patients, surgical resection may have to be complemented with (neo)adjuvant radiotherapy or medical treatment.

Original languageEnglish (US)
Article number2394942
JournalSurgery Research and Practice
Volume2016
DOIs
StatePublished - Jan 1 2016

Fingerprint

Renal Cell Carcinoma
Nephrectomy
Recurrence
Neoplasms
Kidney
Survival Rate
Cryosurgery
Adjuvant Radiotherapy
Kidney Neoplasms
Robotics
Reoperation
Therapeutics
Morbidity

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Surgical Management of Local Recurrences of Renal Cell Carcinoma. / Acar, Ömer; Şanli, Öner.

In: Surgery Research and Practice, Vol. 2016, 2394942, 01.01.2016.

Research output: Contribution to journalReview article

@article{1012ccbf8d4e479aa431fd6b45bf53c3,
title = "Surgical Management of Local Recurrences of Renal Cell Carcinoma",
abstract = "Surgical resection either in the form of radical nephrectomy or in the form of partial nephrectomy represents the mainstay options in the treatment of kidney cancer. In most instances, resecting the tumor bearing kidney or the tumor itself provides durable cancer specific survival rates. However, recurrences may rarely develop in the renal fossa or remnant kidney. Despite its rarity, locally recurrent RCC is a challenging condition in terms of the possible management options and relatively poor prognosis. If technically feasible, wide surgical excision and ensuring negative surgical margins are the most effective treatment options. Repeat surgeries (completion nephrectomy, excision of locally recurrent tumor, or repeat partial nephrectomy) may often be complicated, and perioperative morbidity is a major concern. Open approach has been extensively applied in this context and 5-year cancer specific survival rates have been reported to be around 50{\%}. The roles of minimally invasive surgical options (laparoscopic and robotic approach) and nonsurgical alternatives (cryoablation, radiofrequency ablation) have yet to be described. In selected patients, surgical resection may have to be complemented with (neo)adjuvant radiotherapy or medical treatment.",
author = "{\"O}mer Acar and {\"O}ner Şanli",
year = "2016",
month = "1",
day = "1",
doi = "10.1155/2016/2394942",
language = "English (US)",
volume = "2016",
journal = "Surgery Research and Practice",
issn = "2356-7759",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Surgical Management of Local Recurrences of Renal Cell Carcinoma

AU - Acar, Ömer

AU - Şanli, Öner

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Surgical resection either in the form of radical nephrectomy or in the form of partial nephrectomy represents the mainstay options in the treatment of kidney cancer. In most instances, resecting the tumor bearing kidney or the tumor itself provides durable cancer specific survival rates. However, recurrences may rarely develop in the renal fossa or remnant kidney. Despite its rarity, locally recurrent RCC is a challenging condition in terms of the possible management options and relatively poor prognosis. If technically feasible, wide surgical excision and ensuring negative surgical margins are the most effective treatment options. Repeat surgeries (completion nephrectomy, excision of locally recurrent tumor, or repeat partial nephrectomy) may often be complicated, and perioperative morbidity is a major concern. Open approach has been extensively applied in this context and 5-year cancer specific survival rates have been reported to be around 50%. The roles of minimally invasive surgical options (laparoscopic and robotic approach) and nonsurgical alternatives (cryoablation, radiofrequency ablation) have yet to be described. In selected patients, surgical resection may have to be complemented with (neo)adjuvant radiotherapy or medical treatment.

AB - Surgical resection either in the form of radical nephrectomy or in the form of partial nephrectomy represents the mainstay options in the treatment of kidney cancer. In most instances, resecting the tumor bearing kidney or the tumor itself provides durable cancer specific survival rates. However, recurrences may rarely develop in the renal fossa or remnant kidney. Despite its rarity, locally recurrent RCC is a challenging condition in terms of the possible management options and relatively poor prognosis. If technically feasible, wide surgical excision and ensuring negative surgical margins are the most effective treatment options. Repeat surgeries (completion nephrectomy, excision of locally recurrent tumor, or repeat partial nephrectomy) may often be complicated, and perioperative morbidity is a major concern. Open approach has been extensively applied in this context and 5-year cancer specific survival rates have been reported to be around 50%. The roles of minimally invasive surgical options (laparoscopic and robotic approach) and nonsurgical alternatives (cryoablation, radiofrequency ablation) have yet to be described. In selected patients, surgical resection may have to be complemented with (neo)adjuvant radiotherapy or medical treatment.

UR - http://www.scopus.com/inward/record.url?scp=85010055729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010055729&partnerID=8YFLogxK

U2 - 10.1155/2016/2394942

DO - 10.1155/2016/2394942

M3 - Review article

VL - 2016

JO - Surgery Research and Practice

JF - Surgery Research and Practice

SN - 2356-7759

M1 - 2394942

ER -